CLIA, Regulatory, & Accreditation
|2 min read
FDA Predetermined Change Control Plans May Aid LDT Modifications
A new PCCP draft guidance outlines what elements the agency expects in these plans|1 min read
A2LA Accredits First Clinical Laboratory in US to New Version of ISO 15189
ADL Health meets requirements of ISO 15189:2022, the latest version of the standard|3 min read
Laboratory Training Goes Virtual
The CDC’s OneLab VR lab environment offers an expanding suite of lab training scenarios in real-time from around the worldUpdated |2 min read
Webinar Recap: LDT Compliance Requirements for FDA Final Rule
Christine P. Bump shares key insights from the FDA’s August 22 webinar on LDTs complianceAvailable on Demand
Loper Bright and the Potential Impact on the Laboratory Industry
Join Today's Clinical Lab, G2 Intelligence and Christine P. Bump to learn about Loper Bright and the Potential Impact on the Laboratory IndustrySponsored by
|2 min read
Association for Molecular Pathology Challenges FDA in Lawsuit against Final Rule on Laboratory-Developed Test Regulation
Drastic policy change will stifle diagnostic innovation, impose billions of unnecessary dollars in healthcare mandates, and threaten patient access to essential medical procedures|3 min read
The Quiet Brilliance of Efficient Water Purification
Impeccable Water Purification Systems Power the Lab With Minimal Staff InteractionSponsored by
|1 min read
Tips for Improving Your Lab's Sustainability Practices
Learn actionable strategies to reduce waste, conserve energy, and optimize water use in your labSponsored by
Updated |3 min read
Forever Chemical Pollution Can Now Be Tracked via Carbon Fingerprinting
The new method could help authorities trace forever chemicals to their source after they end up in aquifers, waterways, or soilUpdated |1 min read
A Clinical Lab Manager’s Guide to Antimicrobial Stewardship
Explore the latest strategies and essential elements for effective antimicrobial stewardship in health care settingsSponsored by
|3 min read
FDA's Draft Guidances for Emergency Use LDTs Spark Mixed Reactions
Public comments to the FDA’s draft guidances proposing enforcement policies for LDTs with and without a 564 Declared Emergency reveal a mix of support and opposition|3 min read















